Skip to main content
FERMENTA BIOTECH LIMITED logo

FERMENTA BIOTECH LIMITED — Investor Relations & Filings

Ticker · FERMENTA ISIN · INE225B01021 LEI · 335800VNTNWW8G1U9314 BSE.NS Manufacturing
Open in API
Filings indexed 671 across all filing types
Latest filing 2021-06-30 Earnings Release
Country IN India
Listing BSE.NS FERMENTA

About FERMENTA BIOTECH LIMITED

https://fermentabiotech.com

Fermenta Biotech Limited is a specialized biotechnology company primarily focused on the development and manufacture of Vitamin D3 (Cholecalciferol). As one of the few vertically integrated manufacturers globally, the company produces Vitamin D3 for diverse applications, including pharmaceuticals, dietary supplements, human nutrition, and animal feed. Beyond its core Vitamin D3 portfolio, the company offers a range of specialty enzymes, particularly for the synthesis of beta-lactam antibiotics, and provides environmental solutions through its biotechnology expertise. Fermenta Biotech emphasizes high-quality standards, maintaining various international certifications for its manufacturing facilities. Its product offerings extend to premixes and value-added formats designed to meet specific formulation requirements. The company serves a global clientele, leveraging its research and development capabilities to innovate in the fields of nutrition and biotechnology.

Recent filings

Filing Released Lang Actions
Further to our intimation dated June 29, 2021 regarding approval of Audited Financial Results (Standalone and Consolidated) by the Board of Directors for the quarter and financial year ....
Earnings Release Classification · 95% confidence The document is an Earnings Presentation for the quarter 4 and financial year ended March 31, 2021, as indicated by the subject line and multiple references throughout the text. It includes detailed financial highlights, operational and consolidated income statements, and performance metrics for Q4 FY21 and FY21. The document is about 15,000 characters long, contains substantive financial data and analysis, and is not merely an announcement or a certification. Therefore, it fits the definition of an Earnings Release (ER), which is the initial announcement of quarterly/periodical financial results with key highlights and financial data. Q4 2021
2021-06-30 English
Fermenta Biotech Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from August 27, 2021 to September 03, 2021 (both days inclusive) ....
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the stock exchange (BSE Limited) reporting the outcome of a Board Meeting held on June 29, 2021. It announces the date of the upcoming Annual General Meeting (AGM), dividend details including record date, book closure dates, and dividend payment date. The document references compliance with SEBI Listing Regulations and the Companies Act. It does not contain the full Annual Report or financial statements but rather announces the scheduling of the AGM and related dividend information. The document length is short (2887 characters) and it serves as an official announcement of board decisions rather than the report itself. Therefore, it fits best under the category of Declaration of Voting Results & Voting Rights Announcements (DVA) or possibly Regulatory Filings (RNS). However, since it is about the outcome of a board meeting including AGM date and dividend declaration, the most appropriate classification is Regulatory Filings (RNS) as it is a general regulatory announcement and does not report voting results or detailed AGM materials. Confidence is high due to clear references to board meeting outcomes and regulatory compliance without inclusion of full reports or financial data.
2021-06-30 English
Fermenta Biotech Ltd has informed BSE that the Board of Directors of the Company at its meeting held on June 29, 2021, inter alia, has recommended final equity dividend @ Rs. 2.50/- per ....
Regulatory Filings
2021-06-29 English
1. Annual General Meeting (AGM) Date 2. Dividend and Book Closure 3. Dividend Payment Date
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the stock exchange (BSE Limited) reporting the outcome of a Board Meeting held on June 29, 2021. It announces the date of the upcoming Annual General Meeting (AGM), dividend details including record date, book closure dates, and dividend payment date. The document references compliance with SEBI Listing Regulations and the Companies Act. It does not contain the full Annual Report or financial statements but rather announces the scheduling of the AGM and related dividend information. The document length is short (2887 characters) and it serves as an official announcement of board decisions rather than the report itself. Therefore, it fits best under the category of Declaration of Voting Results & Voting Rights Announcements (DVA) or possibly Regulatory Filings (RNS). However, since it is specifically about the outcome of a Board Meeting including AGM date and dividend declaration, the most appropriate classification is Regulatory Filings (RNS) as it is a general regulatory announcement and does not report voting results or detailed AGM materials. Confidence is high due to clear regulatory references and content type.
2021-06-29 English
1. Approved the Audited Financial Results (Standalone and Consolidated) for the quarter and financial year ended March 31, 2021 as per Regulation 33 of the Listing Regulations. ....
Regulatory Filings
2021-06-29 English
Pursuant to Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith photocopy of the newspaper ....
Regulatory Filings
2021-06-28 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.